MELK inhibitor

MELK inhibitor · OncoTherapy Science, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MELK inhibitor, covering 2026-02-25 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer [Phase 1]

See pricing